Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles - PubMed (original) (raw)
Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles
Pedro A Reche et al. Immunogenetics. 2004 Sep.
Free article
Abstract
We introduced previously an on-line resource, RANKPEP that uses position specific scoring matrices (PSSMs) or profiles for the prediction of peptide-MHC class I (MHCI) binding as a basis for CD8 T-cell epitope identification. Here, using PSSMs that are structurally consistent with the binding mode of MHC class II (MHCII) ligands, we have extended RANKPEP to prediction of peptide-MHCII binding and anticipation of CD4 T-cell epitopes. Currently, 88 and 50 different MHCI and MHCII molecules, respectively, can be targeted for peptide binding predictions in RANKPEP. Because appropriate processing of antigenic peptides must occur prior to major histocompatibility complex (MHC) binding, cleavage site prediction methods are important adjuncts for T-cell epitope discovery. Given that the C-terminus of most MHCI-restricted epitopes results from proteasomal cleavage, we have modeled the cleavage site from known MHCI-restricted epitopes using statistical language models. The RANKPEP server now determines whether the C-terminus of any predicted MHCI ligand may result from such proteasomal cleavage. Also implemented is a variability masking function. This feature focuses prediction on conserved rather than highly variable protein segments encoded by infectious genomes, thereby offering identification of invariant T-cell epitopes to thwart mutation as an immune evasion mechanism.
Similar articles
- Prediction of MHC class I binding peptides using profile motifs.
Reche PA, Glutting JP, Reinherz EL. Reche PA, et al. Hum Immunol. 2002 Sep;63(9):701-9. doi: 10.1016/s0198-8859(02)00432-9. Hum Immunol. 2002. PMID: 12175724 - Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S, Karosiene E, Dhanda SK, Jurtz V, Edwards L, Nielsen M, Sette A, Peters B. Paul S, et al. Front Immunol. 2018 Aug 6;9:1795. doi: 10.3389/fimmu.2018.01795. eCollection 2018. Front Immunol. 2018. PMID: 30127785 Free PMC article. - Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D, Khuri N, Dong GQ, Winter MB, Shifrut E, Friedman N, Craik CS, Pratt KP, Paz P, Aswad F, Sali A. Schneidman-Duhovny D, et al. PLoS One. 2018 Nov 6;13(11):e0206654. doi: 10.1371/journal.pone.0206654. eCollection 2018. PLoS One. 2018. PMID: 30399156 Free PMC article. - Combining computer algorithms with experimental approaches permits the rapid and accurate identification of T cell epitopes from defined antigens.
Schirle M, Weinschenk T, Stevanović S. Schirle M, et al. J Immunol Methods. 2001 Nov 1;257(1-2):1-16. doi: 10.1016/s0022-1759(01)00459-8. J Immunol Methods. 2001. PMID: 11687234 Review. - Peptide binding to major histocompatibility complex molecules.
Barber LD, Parham P. Barber LD, et al. Annu Rev Cell Biol. 1993;9:163-206. doi: 10.1146/annurev.cb.09.110193.001115. Annu Rev Cell Biol. 1993. PMID: 7506551 Review. No abstract available.
Cited by
- Integrating machine learning to advance epitope mapping.
Grewal S, Hegde N, Yanow SK. Grewal S, et al. Front Immunol. 2024 Sep 30;15:1463931. doi: 10.3389/fimmu.2024.1463931. eCollection 2024. Front Immunol. 2024. PMID: 39403389 Free PMC article. Review. - Enhancing Wound Healing and Anti-Inflammatory Effects by Combination of CIGB-258 and Apolipoprotein A-I against Carboxymethyllysine Toxicity in Zebrafish: Insights into Structural Stabilization and Antioxidant Properties.
Cho KH, Lee Y, Lee SH, Kim JE, Bahuguna A, Dominguez-Horta MDC, Martinez-Donato G. Cho KH, et al. Antioxidants (Basel). 2024 Aug 28;13(9):1049. doi: 10.3390/antiox13091049. Antioxidants (Basel). 2024. PMID: 39334708 Free PMC article. - In silico advancements in Peptide-MHC interaction: A molecular dynamics study of predicted glypican-3 peptides and HLA-A*11:01.
Chieochansin T, Sanachai K, Darai N, Chiraphapphaiboon W, Choomee K, Yenchitsomanus PT, Thuwajit C, Rungrotmongkol T. Chieochansin T, et al. Heliyon. 2024 Aug 22;10(17):e36654. doi: 10.1016/j.heliyon.2024.e36654. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39263056 Free PMC article. - Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.
Fernandez SA, Pelaez-Prestel HF, Fiyouzi T, Gomez-Perosanz M, Reiné J, Reche PA. Fernandez SA, et al. Front Immunol. 2024 Jul 18;15:1425374. doi: 10.3389/fimmu.2024.1425374. eCollection 2024. Front Immunol. 2024. PMID: 39091504 Free PMC article. - Design and computational analysis of an effective multi-epitope vaccine candidate using subunit B of cholera toxin as a build-in adjuvant against urinary tract infections.
Rezaei M, Habibi M, Ehsani P, Asadi Karam MR, Bouzari S. Rezaei M, et al. Bioimpacts. 2024;14(1):27513. doi: 10.34172/bi.2023.27513. Epub 2023 Aug 5. Bioimpacts. 2024. PMID: 38327629 Free PMC article.
References
- Bioinformatics. 2003 Oct 12;19(15):1978-84 - PubMed
- J Mol Biol. 2003 Aug 15;331(3):623-41 - PubMed
- J Mol Biol. 2000 May 5;298(3):417-29 - PubMed
- Proteins. 1998 Dec 1;33(4):460-74 - PubMed
- J Immunol Methods. 2003 Apr 1;275(1-2):19-29 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials